Position in LH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,848,000
-$19,433,860 QoQ
Shares Held
31,600
-70.2% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#187
of 1,040 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $618,295,595 across 13 Diagnostics & Research names. LH ranks #12 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
406,154 | $203,629,369 | |
| 2 | DHR |
Danaher Corp /De/
|
452,595 | $86,210,295 | |
| 3 | GH |
Guardant Health, Inc.
|
371,763 | $55,775,602 | |
| 4 | WAT |
Waters Corp /De/
|
144,556 | $54,214,282 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
213,480 | $48,415,129 | |
| 6 | A |
Agilent Technologies, Inc.
|
321,166 | $42,660,479 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
70,301 | $37,009,258 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
21,776 | $27,819,057 |
All Filings in LH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,848,000 | 31,600 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $28,281,860 | 106,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $36,879,360 | 147,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,803,322 | 23,700 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,221,487 | 23,700 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $16,315,074 | 70,100 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $9,779,122 | 42,644 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $4,253,359 | 20,900 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||